Detalhe da pesquisa
1.
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1-2 trial.
Lancet HIV
; 9(5): e332-e340, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35489377